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ABSTRAK
Pembesaran payudara menggunakan implan silikon adalah prosedur estetik yang 
popular dengan profil keselamatan yang tinggi. Jangkitan implan silikon payudara 
adalah entiti klinikal yang jarang berlaku. Rawatan biasanya melibatkan pembuangan 
implan dan penggunaaan antibiotik. Laporan ini mengetengahkan satu kes jangkitan 
implan payudara yang berlaku hampir 15 tahun selepas pembedahan pertama.
Kata kunci: payudara, implan, silikon, jangkitan, bengkak
ABSTRACT
Breast augmentation using silicone implant is a common and popular aesthetic 
procedure with a high safety profile. Infection of silicone breast implants is a 
rare clinical entity, with skin commensal organisms often implicated as causative 
pathogen. Surgical treatment often involves removal of the implant with salvage 
procedures limited to selected cases. This case highlights a delayed presentation of 
an infected silicone breast implant presenting as a chest wall abscess 15 years after 
initial surgery.
Keywords: breast augmentation, silicone, implant, infection, abscess
haematoma and wound dehiscence. 
Late infection of breast implant is rare, 
but if it does occur can cause a lot of 
issues especially to the surgeon in term 
of establishing the diagnosis, treatment 
options ranging from conservative 
INTRODUCTION
In general, cosmetic breast 
augmentation with silicone implants is a 
safe procedure. It is associated with low 
surgical complications such as infection, 
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treatment with antibiotic alone to 
surgical intervention. We present a case 
of peculiar late breast implant infection 
which involved large area of anterior 
and lateral abdominal wall area that 
eventually underwent massive wound 
debridement with good outcome. 
CASE REPORT
A 33-year-old lady with a history 
of bilateral breast augmentation 
using silicone implants 15 years 
earlier, presented to the emergency 
department with complaint of left flank 
swelling, pain and fever for four days 
duration. The swelling was fluctuant, 
tender and erythematous with a small 
necrotic patch. It extended from the 
lower chest wall on the left to the 
lumbar region on the same side. She 
remained hemodynamically stable 
but her infective parameters such as 
leucocyte count and c- reactive protein 
were markedly elevated. CT scan of 
the thorax and abdomen showed 
significant tissue streakiness in the left 
breast suggesting ruptured left breast 
implant with subcutaneous collection 
extending from the left chest wall to the 
anterior superior iliac spine and para-
spinous region posteriorly. Emergency 
incision drainage and removal of the 
breast implant was undertaken with 
Figure 1: Area of swelling and necrotic patch 
noted over anterior abdominal wall extending 
downwards from the chest wall superiorly
Figure 2: Another picture depicting the area of 
swelling and necrotic patch noted over anterior 
abdominal wall extending downwards from 
the chest wall superiorly
Figure 3:  Coronal view of a CT scan. Blue 
arrow demonstrating the abscess collection 
tracking downwards from the chest wall to the 
left lumbar region
Figure 4: Axial CT scan view. Blue arrow 
showing the ruptured left silicone implant with 
surrounding abscess collection
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1.9L of purulent material drained. Two 
separate incisions were made, one at 
the inframammary fold and a separate 
incision at the most dependent area 
of the swelling over the left flank 
region. Corrugated drains were 
placed in the abscess cavities after 
thorough debridement and irrigation. 
Histopathological examination of 
the silicone implant revealed foreign 
body granuloma, while microbiology 
culture of the purulent material was 
positive for Staphylococcus Aureus. 
Post operatively Cloxacillin was 
administered according to culture 
sensitivity report and subjected to daily 
dressing with saline. Five days later, 
the corrugated drains were removed 
and the patient was discharged home. 
She has since been followed-up in 
the surgical outpatient clinic and has 
shown full recovery. She is keen for 
insertion of a new implant on the same 
side, and she is presently awaiting her 
operation date.
DISCUSSION
Breast augmentation has become 
widely popular with increasing 
emphasis on achieving a more sexually 
appeasing figure. In 2010, breast 
augmentation was the most opted 
for cosmetic surgery in America with 
almost 320,000 women reported to 
have undergone surgical enhancement 
(American Society of Plastic Surgeons 
2012).
 Similarly in Asia, there is also a rise in 
trend of breast augmentation especially 
among young women below the age of 
19. This global hunger for fuller breasts 
has prompted the need to question and 
establish the bio-durability of silicone 
implants. Although the exact bio-
durability of silicone implants remains 
largely a mystery, previous studies have 
reported 10-year rupture rates to vary 
between 10-50% (Holmich et al. 2003; 
Heden et al. 2006; Thorton et al. 1988). 
This would mean that women are likely 
to require implant removal or change of 
implant at least once in their lifetime, if 
not more.
 Infection of silicon breast implants is a 
rare yet the most dreadedcomplication 
with 1-2% of reported incidence. Skin 
commensals such as Staphylococcus 
Aureus, Lactobacillus, and Alpha-
haemolytic Streptococcus have 
have been implicated as common 
causative organisms in the immediate 
post-operative setting (Brown et al. 
2000; Thorton et al. 1988). Delayed 
presentation has been attributed to 
secondary bacterial infection from 
invasive procedures distant to the 
breast tissue or peri-prosthetic infection 
from infection of the breast tissue itself 
leading to strong opposition from 
surgeons against procedures such as 
nipple piercing in patients with breast 
implants in-situ. Prosthetic contracture 
or rupture of implant has also been 
associated with infection and is often 
seen after many years following 
surgery. Cause of implant rupture 
besides being largely idiopathic, 
has also been reported following 
breast compression during routine 
mammography, and trauma (Brown 
et al. 1997). Optimum placement of 
implant in relation to maximizing 
its bio-durability and minimizing 
morbidity is an ongoing debate. 
Although submuscular placement of 
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silicone implant has been attributed to 
increased hematoma formation, there 
has not been any statistical significance 
reported between subglandular or 
submuscular placement in relation to 
infection or implant rupture (Hand et 
al. 2010). Women with silicone implant 
contracture are often asymptomatic 
and incidentally diagnosed during 
mammography. However, there has 
been an increase in evidence to link 
underlying subclinical prostethic 
infection with development of 
contracture as late as 9 years following 
initial surgery (Pajkos et al. 2003; 
Virden et al. 1992). There is currently 
no consensus on removal of contracted 
silicone implant in asymptomatic 
women, although surgery is the 
preferred mainstay of treatment for 
Baker’s grade 3 and beyond.
CONCLUSION
The traditional approach to 
management of infected silicone breast 
implants has always been removal of the 
offending prosthesis, treatment of the 
underlying infection with appropriate 
antibiotics and placement of a new 
implant at a later date. The advents of 
stronger antibiotics in addition to more 
accurate microbiology culture and 
sensitivity reports have paved the way 
for an alternative method of treatment. 
With careful patient selection, mild 
prosthetic infection canbe treated 
non-surgically with antibiotic therapy 
alone for 10 to 14 days followed by 
clinical and radiological reassessment. 
Removal of implant is reserved for 
moderate to severe form of infection, 
and failure to respond to antibiotic 
therapy (Spear & Seruya 2010). In our 
patient, the decision for debridement 
and removal of implant was made 
in view of severe ongoing infection 
involving a significant portion of chest 
wall and anterior abdominal wall. 
Subsequent decision to replace the 
removed silicone breast implant should 
depend on patient’s preference, overall 
breast tissue condition and effectiveness 
of previous surgical and antimicrobial 
therapy (Pittet et al. 2005).
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